Important Information

This website is managed by Ultima Markets’ international entities, and it’s important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:

  • You will not be guaranteed Negative Balance Protection
  • You will not be protected by FCA’s leverage restrictions
  • You will not have the right to settle disputes via the Financial Ombudsman Service (FOS)
  • You will not be protected by Financial Services Compensation Scheme (FSCS)
  • Any monies deposited will not be afforded the protection required under the FCA Client Assets Sourcebook. The level of protection for your funds will be determined by the regulations of the relevant local regulator.

Note: UK clients are kindly invited to visit https://www.ultima-markets.co.uk/. Ultima Markets UK expects to begin onboarding UK clients in accordance with FCA regulatory requirements in 2026.

If you would like to proceed and visit this website, you acknowledge and confirm the following:

  • 1.The website is owned by Ultima Markets’ international entities and not by Ultima Markets UK Ltd, which is regulated by the FCA.
  • 2.Ultima Markets Limited, or any of the Ultima Markets international entities, are neither based in the UK nor licensed by the FCA.
  • 3.You are accessing the website at your own initiative and have not been solicited by Ultima Markets Limited in any way.
  • 4.Investing through this website does not grant you the protections provided by the FCA.
  • 5.Should you choose to invest through this website or with any of the international Ultima Markets entities, you will be subject to the rules and regulations of the relevant international regulatory authorities, not the FCA.

Ultima Markets wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.

By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Ultima Markets entity.

I confirm my intention to proceed and enter this website Please direct me to the website operated by Ultima Markets , regulated by the FCA in the United Kingdom

Important Notice

Ultima Markets does not have an establishment in Singapore and does not operate from Singapore.

Ultima Markets does not provide products or services to citizens or residents of Singapore, and account applications from Singapore citizens or residents will not be accepted.

If you are a citizen or resident of Singapore, please do not open an account or use Ultima Markets’ products or services.

By selecting “Acknowledge and Continue Browsing”, you confirm that you are accessing this website on your own initiative and that your access is not the result of any direct marketing, targeted advertising, solicitation, or promotional activity by Ultima Markets.

Nothing on this website constitutes an offer, solicitation, or promotion of products or services in any jurisdiction where such activity is prohibited. You are responsible for ensuring that your access to and use of this website complies with applicable local laws and regulations.

Acknowledge and Enter the Website
Roll Arrow

Anthropic IPO:ANT 與 ANT.24H 股票差價合約登陸 MT5

在 Anthropic 于纳斯达克上市前,Ultima Markets 将在 MT5 推出 ANT 与 ANT.24H 股票差价合约,具体安排以产品规格及市场状况为准。

在预期的 Anthropic IPO 到来前,Ultima Markets 将推出全新股票差价合约交易品种 ANT 与 ANT.24H。

Ultima 为 Anthropic IPO 推出 ANT 与 ANT.24H

Anthropic 预计将于近期在纳斯达克上市,有望让这家今年最受关注的人工智能公司之一进入公开市场。

在预期的 Anthropic IPO 到来前,Ultima Markets 欣然宣布,即将推出两项全新股票差价合约交易品种:ANT 与 ANT.24H。

两项交易品种计划于 Anthropic 正式宣布公开交易后的两小时内,在 Ultima Markets 的 MT5 服务器上线,具体时间取决于市场状况、流动性及平台准备情况。

ANT 与 ANT.24H 将在 MT5 上线

上线初期,ANT 与 ANT.24H 将仅在 Ultima Markets 的 MetaTrader 5 服务器提供。

Ultima Markets 网页端及 App 的上线安排将于稍后确认。客户应留意 Ultima Markets 官方公告,以了解后续平台更新。

交易品种上线后,MT5 用户可在“市场报价”窗口搜索 ANT 或 ANT.24H。

请注意,ANT 与 ANT.24H 均为股票差价合约。交易这些产品并不代表持有 Anthropic 股票,也不享有股东权利。

产品规格

两项全新交易品种的初步规格如下:

产品规格ANTANT.24H
交易平台仅限 MT5仅限 MT5
杠杆1:101:10
最小交易手数0.1 手0.1 手
最大交易手数1,000 手1,000 手
报价小数位数22
计划上线时间正式开始交易后的两小时内正式开始交易后的两小时内
网页端及 App 上线安排待确认待确认

ANT 与 ANT.24H 上线后,最终交易时间、保证金要求、点差及其他合约条件将显示于 MT5 的交易品种规格中。相关规格尚待确认,并可能受到当时市场状况的影响。

如何在 MT5 查找 ANT 与 ANT.24H

两项交易品种启用后,客户可按以下步骤查找:

  1. 在 MT5 登录 Ultima Markets 账户。
  2. 打开“市场报价”窗口。
  3. 右键点击并选择“交易品种”。
  4. 搜索 ANT 或 ANT.24H。
  5. 选择所需交易品种,并将其添加至“市场报价”。

下单前,客户应通过 MT5 的交易品种规格查看最新交易条件。

Anthropic IPO 概览

Anthropic 已申请将其 A 类普通股在纳斯达克全球精选市场上市,股票代码为 ANT。

高盛与摩根士丹利担任承销团牵头机构,公司申报文件还列出了另外 20 家机构,包括摩根大通、花旗集团、巴克莱、富国证券、美银证券及德意志银行证券。

市场报道称,Anthropic 可能寻求筹集高达 1,000 亿美元的资金,估值最高可能达到 2 万亿美元。若实现,此次发行可能成为有史以来规模最大的 IPO。

不过,这些数字仍属于推测性的市场估计,尚未在 Anthropic 修订后的 S-1 申报文件中获得确认。最终募资目标及估值将取决于公司的官方 IPO 披露及市场状况。

为何 Anthropic IPO 备受市场关注

Anthropic 的 IPO 申报文件显示,公司业务迅速扩张,2026 年上半年营收约达 162.9 亿美元,约为上年同期的 14 倍。公司还公布,第二季度营业利润为 9.74 亿美元。

Anthropic 的增长、募资计划及潜在估值,让此次上市备受投资者关注。不过,最终 IPO 价格、发行规模及估值仍在讨论中。公司的增长及估值预期并不保证未来股价表现。快速扩张与定价不确定性并存,可能使 ANT 开始交易时出现活跃的市场波动。

符合资格的 Ultima Markets 客户可通过 ANT 与 ANT.24H 股票差价合约参与 Anthropic 股价波动,具体须遵守适用的交易条件。新上市股票可能出现大幅波动、流动性变化、点差扩大及价格跳空,尤其是在最初几个交易时段。

如需进一步了解公司背景,请参阅我们的 Anthropic IPO 文章,了解公司的增长前景、估值争议及主要上市风险。

风险提示

杠杆衍生产品较为复杂,因杠杆作用而存在迅速损失本金的高风险。股票差价合约并不赋予标的股票的所有权,并可能导致客户蒙受重大损失,尤其是在波动加剧及流动性变化期间。你应考虑自己是否了解这些产品的运作方式,以及是否有能力承担高额亏损风险。

一般建议声明

本文所提供的信息仅具一般性质,并未考虑你的个人目标、财务状况或需求。在依据任何信息采取行动前,你应结合自身情况评估其适用性,并查阅我们的法律文件。

地区限制

本网站的信息及服务不面向某些司法管辖区的居民,包括但不限于美国、英国、新加坡及任何受到国际制裁的司法管辖区。产品及服务的提供须遵守适用的当地法律及监管限制。如需更多信息,请联系我们的客户支持团队。

立即分享

  • Article Details
  • Article Details
  • Article Details

Thank you for visiting the Ultima Markets website. Please note that this website is intended for individuals residing in jurisdictions where accessing is permitted by law. Ultima and its affiliated entities do not operate in your home jurisdictions.

By clicking on ''Acknowledge'', you confirm that you are entering this website solely based on your initiative and not as a result of any specific marketing outreach. You wish to obtain information from this website based on reverse solicitation principles, in accordance with the applicable laws of your home jurisdiction.